EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study

Mahdi Sheikh iD, Anush Mukeriya iD, Hana Zahed iD, Xiaoshuang Feng, Hilary A Robbins iD, Oxana Shangina iD, Vsevolod Matveev iD, Paul Brennan, David Zaridze iD

Journal of Clinical Oncology · 20.05.2023 · 41 (15) · 2747-2755

DOI: 10.1200/jco.22.02472 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.05.2023. Verfasst von Mahdi Sheikh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Hauptthemen laut MEDLINE: Smoking Cessation, Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE To investigate whether postdiagnosis smoking cessation may affect the risk of death and disease progression in patients with renal cell carcinoma (RCC) who smoked at the time of diagnosis. METHODS Two hundred twelve patients with primary RCC were recruited between 2007 and 2016 from the Urological Department in N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia. Upon enrollment, a structured questionnaire was completed, and the patients were followed annually through 2020 to repeatedly assess their smoking status and disease progression. Survival probabilities and hazards for all-cause and cancer-specific mortality and disease progression were investigated using extended the Kaplan-Meier method, time-dependent Cox proportional hazards regression, and Fine-Gray competing-risk models. RESULTS Patients were followed for a median of 8.2 years. During this time, 110 cases of disease progression, 100 total deaths, and 77 cancer-specific deaths were recorded. Eighty-four patients (40%) quit smoking after diagnosis. The total person-years at risk for this analysis were 748.2 for continuing smoking and 611.2 for quitting smoking periods. At 5 years of follow-up, both overall survival (85% v 61%) and progression-free survival (80% v 57%) rates were higher during the quitting than continuing smoking periods (both P < .001). In the multivariable time-dependent models, quitting smoking was associated with lower risk of all-cause mortality (hazard ratio [HR], 0.51; 95% CI, 0.31 to 0.85), disease progression (HR, 0.45; 95% CI, 0.29 to 0.71), and cancer-specific mortality (HR, 0.54; 95% CI, 0.31 to 0.93). The beneficial effect of quitting smoking was evident across all subgroups, including light smokers versus moderate-heavy smokers and those with early-stage versus late-stage tumors. CONCLUSION Quitting smoking after RCC diagnosis may significantly improve survival and reduce the risk of disease progression and cancer mortality among patients who smoke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationCarcinoma, Renal CellKidney NeoplasmsHumansProspective StudiesDisease ProgressionRisk Factors

Autor:innen und Institutionen

  • Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Department of Epidemiology, N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.
  • Department of Urology, N.N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.

ORCID-Profile: Mahdi Sheikh, Anush Mukeriya, Hana Zahed, Hilary A Robbins, Oxana Shangina, Vsevolod Matveev, David Zaridze

Förderung

  • World Health Organization

Zitieren

APA

Sheikh, M., Mukeriya, A., Zahed, H., Feng, X., Robbins, H. A., Shangina, O., Matveev, V., Brennan, P., & Zaridze, D. (2023). Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study. Journal of Clinical Oncology, 41(15), 2747-2755. https://doi.org/10.1200/jco.22.02472

Vancouver

Sheikh M, Mukeriya A, Zahed H, Feng X, Robbins HA, Shangina O, et al. Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study. Journal of Clinical Oncology. 2023;41(15):2747-2755. doi:10.1200/jco.22.02472

BibTeX
@article{Sheikh2023,
  author = {Sheikh, Mahdi and Mukeriya, Anush and Zahed, Hana and Feng, Xiaoshuang and Robbins, Hilary A and Shangina, Oxana and Matveev, Vsevolod and Brennan, Paul and Zaridze, David},
  title = {Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study},
  journal = {Journal of Clinical Oncology},
  year = {2023},
  volume = {41},
  number = {15},
  pages = {2747--2755},
  doi = {10.1200/jco.22.02472}
}
Kostenlos starten →